
Show Notes
Koda Signal daily AI briefing for 2026-09-17.
In this episode: • Anthropic's Enterprise Footprint Widens: Novo Nordisk is adopting Anthropic's models across research and development workflows to, in its words, 'supercharge' drug discovery. On the same day, Salesforce's AIforce routes CRM data, permissions and business logic into Claude, Slack and Amazon without users opening Salesforce, enforcing record-level permissions when an outside agent queries the data. Anthropic is gaining both a pharmaceutical customer and a distribution channel through a rival's platform. • Roadmaps Outnumber Releases: Huawei's Ascend 960, positioned as China's strongest answer to Nvidia, targets commercial availability in 2027, making the Shanghai unveiling a signal of intent rather than shipping silicon. Sam Altman's 'big ship this week' and 'ship x 6' for DevDay come with no announced product, and GPT-6 Sol reports remain speculation. Both stories reward reading the calendar carefully and discounting the headline.
Full briefing: https://www.koda.community/morning-briefing-koda-2026-09-17.html
More from The Koda Signal
Koda Signal daily AI briefing for 2026-10-24.
Koda Signal daily AI briefing for 2026-10-23.
Koda Signal daily AI briefing for 2026-10-21.
Koda Signal daily AI briefing for 2026-10-20.
Koda Signal daily AI briefing for 2026-10-19.